Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ingrid Jakobsen Falk
Pharmacogenetic Study of the Impact of ABCB1 Single-Nucleotide Polymorphisms on Lenalidomide Treatment Outcomes in Patients With Multiple Myeloma: Results From a Phase IV Observational Study and Subsequent Phase II Clinical Trial
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Related publications
Clinical and Biomarker Outcomes of the Phase II Vandetanib Study From the BATTLE Trial
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Phase I/Ii Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients With High Risk (HR) Multiple Myeloma (MM)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Phase II Trial to Investigate Efficacy and Safety of Bendamustine, Dexamethasone and Thalidomide in Relapsed or Refractory Multiple Myeloma Patients After Treatment With Lenalidomide and Bortezomib
British Journal of Haematology
Hematology
Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Relapsed or Refractory Multiple Myeloma: A Phase 1b Study
American Journal of Hematology
Hematology
Phase I Trial of Lenalidomide and CCI-779 in Patients With Relapsed Multiple Myeloma: Evidence for Lenalidomide–CCI-779 Interaction via P-Glycoprotein
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase II Trial of Karenitecin in Patients With Malignant Melanoma: Clinical and Translational Study
Clinical Cancer Research
Cancer Research
Oncology
Melphalan, Lenalidomide and Dexamethasone for the Treatment of Immunoglobulin Light Chain Amyloidosis: Results of a Phase II Trial
Haematologica
Hematology
Phase I/Ii Study of Carfilzomib, Bendamustine, and Dexamethasone (CBD) in Patients With Newly Diagnosed Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology
A Phase II Trial of Pan-Kir2d Blockade With IPH2101 in Smoldering Multiple Myeloma
Haematologica
Hematology
